Back

Cardiovascular outcome trials up to 2023: it's all about LDL-C lowering

26 August 2023 (12:55 - 13:10)
Organised by: Logo
Congress Presentation Part of: Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials Lipid-Lowering Agents Open Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Professor Ulrich Laufs

University Hospital Leipzig, Leipzig (Germany)

4 More presentations in this session

Presentation thumbnail
Setting the stage: LDL-C and cardiovascular risk
Professor L. Tokgozoglu (Ankara, TR)
Slides
Presentation thumbnail
Data from 2023: it’s still all about LDL-C lowering
Professor S. Nicholls (Melbourne, AU)
Slides
Presentation thumbnail
Panel discussion and Q&A
Professor L. Tokgozoglu (Ankara, TR) Professor U. Laufs (Leipzig, DE) Professor S. Nicholls (Melbourne, AU)
Slides
Presentation thumbnail
Summary and meeting close
Professor U. Laufs (Leipzig, DE) Professor L. Tokgozoglu (Ankara, TR) Professor S. Nicholls (Melbourne, AU)
Slides

Access the full session

Session thumbnail
Latest advancements in low-density lipoprotein cholesterol (LDL-C) lowering therapies and cardiovascular outcome trials
Video

The Event

Event poster

ESC Congress 2023

26 August 2023 12:55 CET
You may be interested in
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them
thumbnail
Webinar
New trial evidence in the field of lipid management
thumbnail
Congress Presentation
2025 Focused Update of the 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources